These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24916329)

  • 1. Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide.
    Cheong H; Lee SS; Lee JS; Kim J; Kim SW; Lee WJ
    J Magn Reson Imaging; 2015 May; 41(5):1218-27. PubMed ID: 24916329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease.
    Asanuma T; Ono M; Kubota K; Hirose A; Hayashi Y; Saibara T; Inanami O; Ogawa Y; Enzan H; Onishi S; Kuwabara M; Oben JA
    Gut; 2010 Feb; 59(2):258-66. PubMed ID: 19919948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of impaired phagocytic function of Kupffer cells in an obstructive cholangitis rat model using superparamagnetic iron oxide MRI and contrast-enhanced ultrasound.
    Lee JH; Kim JH; Lee S; Han JK
    Acta Radiol; 2019 Apr; 60(4):407-414. PubMed ID: 30724596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the severity of nonalcoholic steatohepatitis with superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Tomita K; Tanimoto A; Irie R; Kikuchi M; Yokoyama H; Teratani T; Suzuki T; Taguchi T; Noguchi M; Ohkura T; Hibi T
    J Magn Reson Imaging; 2008 Dec; 28(6):1444-50. PubMed ID: 19025953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation.
    Tonan T; Fujimoto K; Qayyum A; Morita Y; Nakashima O; Ono N; Kawahara A; Kage M; Hayabuchi N; Ueno T
    J Gastroenterol Hepatol; 2012 Apr; 27(4):789-96. PubMed ID: 22188204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.
    Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES
    Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
    Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
    J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.
    Okada M; Katsube T; Kumano S; Kagawa Y; Araki T; Tsuda N; Okuaki T; Imaoka I; Tanigawa N; Ishii K; Murakami T
    Acta Radiol; 2011 Jul; 52(6):658-64. PubMed ID: 21498305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.
    Tanimoto A; Yuasa Y; Shinmoto H; Jinzaki M; Imai Y; Okuda S; Kuribayashi S
    Radiology; 2002 Mar; 222(3):661-6. PubMed ID: 11867782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of SPIO-enhanced MRI in the detection of malignant liver lesions.
    Savranoglu P; Obuz F; Karasu S; Coker A; Secil M; Sagol O; Igci E; Dicle O; Astarcioglu I
    Clin Imaging; 2006; 30(6):377-81. PubMed ID: 17101405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
    Macarini L; Marini S; Murrone M; Ettorre GC
    Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of superparamagnetic iron oxide nanoparticles in the liver of body-temperature-controlled mice using dynamic susceptibility contrast magnetic resonance imaging and an empirical mathematical model.
    Murase K; Assanai P; Takata H; Matsumoto N; Saito S; Nishiura M
    Magn Reson Imaging; 2015 Jun; 33(5):600-10. PubMed ID: 25683514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
    Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
    World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.
    Yamada T; Kashiwagi Y; Rokugawa T; Kato H; Konishi H; Hamada T; Nagai R; Masago Y; Itoh M; Suganami T; Ogawa Y; Abe K
    Magn Reson Imaging; 2019 Apr; 57():210-217. PubMed ID: 30465867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of superparamagnetic iron oxide using inversion recovery balanced steady-state free precession.
    Pelot NA; Bowen CV
    Magn Reson Imaging; 2013 Jul; 31(6):953-60. PubMed ID: 23601361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.
    Wu Z; Cheng ZL; Yi ZL; Xie MW; Zeng H; Lu LJ; Xu X; Shen J
    J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis.
    Yoon MA; Kim SH; Park HS; Lee DH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2009 Oct; 44(10):641-9. PubMed ID: 19724237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hepatic signal recovery on ferucarbotran-enhanced magnetic resonance images: an experimental study in rat livers with gadolinium chloride-induced Kupffer cell damage.
    Furuta T; Yamaguchi M; Nakagami R; Akahane M; Minami M; Ohtomo K; Moriyama N; Fujii H
    MAGMA; 2013 Jun; 26(3):313-24. PubMed ID: 23117343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.